Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Turn Biotechnologies acquires drug delivery tech from Harvard & Vesigen Therapeutics to expand mRNA aging therapies; CEO Anja Krammer aims for 2026 clinical trialsRead More

What's Trending

Inside Northeastern’s efforts to keep students safe in the Middle East

Voting tech company says it’s being vindictively prosecuted by Trump DOJ

Wake Forest vs Virginia Tech Prediction, Picks & Odds for Today’s ACC Tournament Game

Marty Singer’s Law Firm Has A New Name

Trump loyalist Ed Martin faces disciplinary case over DOJ threat against Georgetown Law

Ohio judge rules that Kalshi is sports betting and must adhere to state law

Virginia Poised to Add Menopause Protections Onto Job Bias Law

DeWine calls for Ohio laws on AI, seat belts in final State of the State speech

Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Voting tech company says it’s being vindictively prosecuted by Trump DOJ

Wake Forest vs Virginia Tech Prediction, Picks & Odds for Today’s ACC Tournament Game

Voting tech firm Smartmatic seeks to dismiss money laundering charge as part of Trump’s ‘campaign of retribution’ after 2020 election loss

Bank of America poaches four top tech bankers to boost tech dealmaking, memos show

Leave A Reply Cancel Reply

What's Trending

Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Related Posts

Leave A Reply Cancel Reply

Subscribe to MGSN